Aquestive Therapeutics targets $44M–$50M revenue in 2025 as Anaphylm launch preparations accelerate Aquestive Therapeutics targets $44M–$50M revenue in 2025 as Anaphylm launch preparations accelerate Post ContentaqstRead More You might also be interested in reading It’s Official: FED Considers CBDC. May 13, 2025 In Mainstream ← Previous post Next post →